Recommend Human Vaccines to your librarian for 2008. Download form here.

Sign up for TOC Alerts

Email this page

Print this page

Research Paper

Buren of Hospital Admissions for Cervical Cancer in Spain During 1999-2002

Angel Gil, María San-Martín, Ruth Gil, Hernández Valentín, Josepa Ribes and Antonio González

Purchase article for $19

Subscribe to this journal for $79/year

Population-based retrospective epidemiological study to estimate the burden of hospitalizations by cervical cancer in Spain. It was conducted by using hospital discharge data from the national surveillance system for hospital data, Conjunto Mínimo Básico de Datos (CMBD). Records of all patients admitted to hospital with a diagnosis of malignant neoplasm of the cervix (ICD-9-MC codes 180.0-180.9) or carcinoma in situ of cervix (ICD-9-MC code 233.1) during a 4-year period (1999-2002), were selected. An annual average of 4,151 hospitalizations with a primary or secondary diagnosis of cervical cancer and 2,761 hospitalizations due to carcinoma in situ were identified. Annually there were 25.5 and 17.0 hospitalizations by cervical cancer and carcinoma in situ per 100,000 women ≥20 years of age, respectively. Hospitalization rate by cervical cancer and carcinoma in situ peaks in women between 45 and 59 years of age (39.4 admissions per 100,000 women) and 30 to 44 years of age (32.2 per 100,000 women), respectively. The mean cost of a hospitalization by cervical cancer and carcinoma in situ was 3,098€ and 2,192€, respectively. The estimated annual cost of hospitalizations for cervical cancer and carcinoma in situ in Spain was 19 million €.

Authors

Angel Gil

Department of Health Sciences, Rey Juan Carlos University, Madrid, Spain

María San-Martín

Medical Department, Sanofi Pasteur MSD, Madrid, Spain

Ruth Gil

Department of Health Sciences, Rey Juan Carlos University, Madrid, Spain

Hernández Valentín

Department of Health Sciences, Rey Juan Carlos University, Madrid, Spain

Josepa Ribes

IDIBELL, Epidemiology and Cancer Registry Unit, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Spain

Antonio González

Medical Department, Sanofi Pasteur MSD, Madrid, Spain

Purchase article for $19

Subscribe to this journal for $79/year